Fundraising FoxBios Partners — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3β inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.
BiotechFort Worth, US
Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Board seatAaron G.L. FletcherAaron G.L. FletcherLeslie W. Kreis, Jr.· per SEC Form D
Co-investorsIllinois VenturesKairos Venture Investments, LlcBiosDEFTA PartnersTech Coast Angels
Convox provides a platform for deploying and managing cloud-native applications across multiple cloud providers including AWS, Google Cloud, and Azure.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareAtlanta, US
David Dollar(CEO)inNoah Zoschke(CTO)inMatt Manning(Founder)in
Co-investorsCurious CapitalGarage CapitalHeavybitY CombinatorInovia CapitalProsperity7 Ventures+4 more
.jpeg)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.